Français
ItalianoBond Genmab 6.25% ( US37230JAA07 ) in USD
| Issuer | Genmab | ||||||
| Market price |  101.25 % ⇌ |
||||||
| Country |  Denmark
|
||||||
| ISIN code |
 US37230JAA07 ( in USD )
|
||||||
| Interest rate | 6.25% per year ( payment 2 times a year) | ||||||
| Maturity | 14/12/2032 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | 200 000 USD | ||||||
| Total amount | 1 500 000 000 USD | ||||||
| Cusip | 37230JAA0 | ||||||
| Standard & Poor's ( S&P ) rating | BB+ ( Non-investment grade speculative ) | ||||||
| Moody's rating | Ba2 ( Non-investment grade speculative ) | ||||||
| Next Coupon | 15/12/2026 ( In 111 days ) | ||||||
| Detailed description |
Genmab is an international biotechnology company specializing in antibody therapeutics for cancer treatment. The Bond issued by Genmab ( Denmark ) , in USD, with the ISIN code US37230JAA07, pays a coupon of 6.25% per year. The coupons are paid 2 times per year and the Bond maturity is 14/12/2032 The Bond issued by Genmab ( Denmark ) , in USD, with the ISIN code US37230JAA07, was rated Ba2 ( Non-investment grade speculative ) by Moody's credit rating agency. The Bond issued by Genmab ( Denmark ) , in USD, with the ISIN code US37230JAA07, was rated BB+ ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||